| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | 0.068 | 0.2 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.07 | 0.2 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |